CePt3Si is a novel heavy fermion superconductor, crystallizing in the CePt3B structure as a tetragonally distorted low symmetry variant of the AuCu3 structure type. CePt3Si exhibits antiferromagnetic order at T(N) approximately 2.2 K and enters into a heavy fermion superconducting state at T(c) approximately 0.75 K. Large values of H(')(c2) approximately -8.5 T/K and H(c2)(0) approximately 5 T refer to heavy quasiparticles forming Cooper pairs. Hitherto, CePt3Si is the first heavy fermion superconductor without a center of symmetry.
The histological prevalence of beta-2 microglobulin amyloidosis (A beta 2m) was evaluated in a prospective study of joint samples obtained at autopsy in 54 patients on hemodialysis (HD) for 2 to 163 (median 47) months, aged 20 to 80 (median 63) years at HD onset. Carpal tunnel syndrome surgery or radiological signs of A beta 2m were present in 2 and 4% of them, respectively. A control group of 34 patients without end-stage renal disease, autopsied during the same period was used as a reference. The 153 sampled joints (1 to 8, median 2 per patient) were sternoclavicular joints (N = 77), shoulders (N = 35), knees (N = 28), others (N = 13). A beta 2m was diagnosed (positive Congo red with typical birefringence and positive immunostaining of deposits for beta 2m) in 26 of 54 (48%) patients. Prevalence reached respectively 21%, 33%, 50%, 90% and 100% within two years, after 2 to 4 years, 4 to 7 years, 7 to 13 years and more than 13 years HD. The calculated sensitivity of the various joints for A beta 2m detection is significantly higher (P < 0.03) for sternoclavicular joints (97%) and knees (91%) than for shoulders (57%). Multivariate stepwise logistic regression with discriminant analysis identified both HD duration (P = 0.0008) and age at HD onset (P = 0.0093) but not diabetic nephropathy (P = 0.23) or gender (P = 0.25) as independent risk factors for A beta 2m. The probability of joint A beta 2m was quantitated as a function of age and HD duration. In conclusion, A beta 2m may be observed in the large joints early after HD onset. Overall prevalence reaches 48% of the patients on HD for a median of 47 months. It is much higher than that reported on the basis of clinical or radiological evidence. The sternoclavicular and knee joints are more frequently (P < 0.03) involved than the shoulder. The easily accessible sternoclavicular joint therefore appears to be the best site for the early detection of A beta 2m. Both HD duration and age at HD onset, but not diabetic nephropathy, are independent risk factors for A beta 2m.
We report on investigations of type I clathrate Si and Ge compounds with Ba
partially substituted by rare earth atoms. Novel compounds from framework-deficient
solid solutions Ba8 Alx Si42−3/4x □4−1/4x
and Ba8 Gax Si42−3/4x □4−1/4x (x = 8, 12, 16;
□, open
square...
lattice defect) have been prepared and characterized. All x-ray intensity data are consistent
with the standardized clathrate I-Ba8Al16Ge30 type structure (space group Pm3̄n).
In rare earth substituted clathrates, Eu2Ba6MxSi46−x (M = Cu,
Al, Ga), rare earth atoms completely occupy the
2a
position and thus form a new quaternary ordered version of the Ba8Al16Ge30
structure type. From a geometrical analysis of clathrate crystal structures, a
systematic scheme for all known clathrate compounds is proposed. All clathrates
studied are metals with low electrical conductivity. The highest Seebeck coefficient
in the present series is deduced for Ba8In16Ge30, S = −75μV K−1,
indicating transport processes dominated by electrons as carriers. The Eu-based
clathrates investigated exhibit long-range magnetic order as high as 32 K for
Eu2Ba6Al8Si36 of presumably ferromagnetic type. Magnetic susceptibility
indicates in all cases a 2+ ground state for the Eu ions, in fine agreement with LIII
absorption edge spectra.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.